The CMS has removed the provider review version of a new database that details financial relationships between healthcare providers and drug and medical-device manufacturers.
The CMS has removed the provider review version of a new database that details financial relationships between healthcare providers and drug and medical-device manufacturers.
It's unclear whether pulling the system offline signals that all its Sunshine Act-mandated information about payments to physicians and teaching hospitals from drug and medical-device makers will be publicly available Sept. 30 as originally scheduled.
“We don't know if that means there will be a delay in the launch of the entire website,” said Dr. Daniel Carlat, director of the Prescription Project at the Pew Charitable Trusts. “This seems just like an appropriate part of the CMS' diligence in making sure the website eventually works smoothly and delivers accurate data once it is launched.”
Read the full story here: http://bit.ly/1oCEoHs
Source: Modern Healthcare
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Same-Day Breast Imaging Gaps Reveal Health Care Disparities
February 18th 2025For this retrospective study, the authors examined data on more than 3 million screening mammographies for more than 1 million female patients; of the screenings, 23.6% had abnormal results and only 6.7% were recommended for biopsy.
Read More